Genetic Screening and Counseling: Family Medicine Obstetrics

Primary Care - Clinics in Office Practice

Volumn 39, Issue 1, 2012, Pages 55-70

  Rodney Arnold, K M ^a   Self, Zachary B ^b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b Surgical Family Medicine Obstetrics   (United States)

Author keywords

Family medicine; Genetic counseling; Genetic screening; Obstetrics

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ALPHA THALASSEMIA; AMNIOCENTESIS; AMNION FLUID; ANEUPLOIDY; AUTOSOMAL RECESSIVE DISORDER; BETA THALASSEMIA; BIRTH DEFECT; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; CONGENITAL DISORDER; CULTURAL FACTOR; CYSTIC FIBROSIS; DOWN SYNDROME; ETHNIC GROUP; FAMILY HISTORY; FIRST TRIMESTER PREGNANCY; GENE MUTATION; GENETIC HISTORY; GENETIC SCREENING; GESTATIONAL AGE; HUMAN; INCIDENCE; INHERITANCE; KARYOTYPING; MATERNAL AGE; MEDICAL ETHICS; NUCHAL TRANSLUCENCY MEASUREMENT; PATERNAL AGE; PATIENT COUNSELING; PATIENT REFERRAL; PEDIGREE; PRENATAL CARE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SECOND TRIMESTER PREGNANCY; SICKLE CELL ANEMIA; TAY SACHS DISEASE; TERATOGENESIS; TRISOMY; TRISOMY 18; ULTRASOUND;

EID: 84856584584     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2011.11.010     Document Type: Review

References (18)

1. Ververs T., Kassenbrood H., Visser G., et al. Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol 2006, 62(10):863-870.
2. Andrade S.E., Raebel M.A., Brown J., et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008, 198(2):194-195.
3. Cooper W.O., Willy M.E., Pont S.J., et al. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007, 196(6):544-545.
4. ACOG Committee on Practice Bulletins ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007, 109(1):217-227.
5. ACOG Committee Opinion #296; first trimester screening for fetal aneuploidy. Obstet Gynecol 2004, 101:215-217.
6. Whithead N.S., Rasmussen S.A., Cox S., et al. Prevalence and predictors of receipt of prenatal information about genetic screening. Prenat Diagn 2006, 26(10):944-950.
7. Kuppermann M., Learman L.A., Gates E., et al. Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstet Gynecol 2006, 107(5):1087-1097.
8. SCREEN: taking a family for familial disease. American Academy of Family Physicians Web site. Available at: Accessed September 19, 2011. http://www.aaafp.org.
9. ACOG Committee Opinion #486:Update on Carrier Screening for Cystic Fibrosis. Obstet Gynecol 2011, 117(4):1028-1031.
10. Saari-Kemppainen A., Karjalainen I., Ylostalo P., et al. Fetal anomalies in a controlled one-stage ultrasound screening trial. A report from the Helsinki Ultrasound Trial. JPerinat Med 1994, 22:279.
11. Saari-Kemppainen A., Karjalainen I., Ylostalo P., et al. Ultrasound screening and perinatal mortality: controlled one-stage ultrasound screening trial. The Helsinki Ultrasound trial. Lancet 1990, 336:387.
12. Crane J.P., LeFevre M.L., Winborn R.C., et al. Arandomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol 1994, 171:392.
13. Abuhamad A.Z. ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin, clinical management guidelines for obstetrician-gynecologist number 98, October 2008. Ultrasonography in pregnancy. Obstet Gynecol 2008, 112:951.
14. Cunningham F.G., MacDonald P.C., Gant N.F., et al. Williams obstetrics 1997, Appleton and Lange, Stamford (CT), p. 972. 20th edition.
15. Murken J. Pranattale diagnostik. Humangenetik 2006, 386-411. Thierne Verlag, Sturttgart (Germany). 7th edition. J. Murken, T. Grimm, E. Holinski-Feder (Eds.).
16. National Society of Genetic Counselors Web site. Available at: Accessed September 15, 2011. http://www.nsgc.org.
17. Clayton E.W. Ethical, legal, and social implications of genomic medicine. NEngl J Med 2003, 349:562.
18. Browner C.H., Preloran H.M., Casado M.C., et al. Genetic counseling gone awry: miscommunication between prenatal genetic service providers and Mexican-origin clients. Soc Sci Med 2003, 56:1933-1946.